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MicroRNAs (miRNAs) are small noncoding RNAs that
regulate gene expression by binding to sequences
within the 30 UTR of mRNAs. Because miRNAs bind
to short sequences with partial complementarity,
target identification is challenging. To complement
the existing target prediction algorithms, we devised
a systematic ‘‘reverse approach’’ screening platform
that allows the empirical prediction of miRNA-target
interactions. Using Drosophila cells, we screened
the 30 untranslated regions (30 UTRs) of the Hedgehog
pathwaygenesagainst agenome-widemiRNA library
and identifiedboth predicted andmanynonpredicted
miRNA-target interactions. We demonstrate that
miR-14 is essential for maintaining the proper level
of Hedgehog signaling activity by regulating its phys-
iological target, hedgehog. Furthermore, elevated
levels of miR-14 suppress Hedgehog signaling acti-
vity by cotargeting its apparent nonphysiological
targets, patched and smoothened. Altogether, our
systematic screening platform is a powerful
approach to identifying both physiological and
apparent nonphysiological targets of miRNAs, which
are relevant in both normal and diseased tissues.INTRODUCTION
MicroRNAs (miRNAs) are endogenously transcribed 19 to 25 nt
small noncoding RNAs that posttranscriptionally regulate target
mRNAs by pairing to complementary sequences, typically found
in their 30 UTRs, to repress mRNA translation, promote transcript
decay or both (Bartel, 2009; Brodersen and Voinnet, 2009; Ghil-
diyal and Zamore, 2009; Hendrickson et al., 2009). In normal
cells, multiple miRNAs cooperate to maintain a proper balance
of various processes, including proliferation, differentiation,
and cell death. In addition, individual miRNAs can regulate mul-
tiple mRNAs further complicating the gene regulatory networks
of miRNAs. Therefore, dysregulation of miRNAs can have detri-
mental cellular consequences and has been associated with
several human diseases ranging from metabolic and inflamma-
tory disease to malignancy (Care` et al., 2007; Fiore et al., 2008;2066 Cell Reports 7, 2066–2077, June 26, 2014 ª2014 The AuthorsKru¨tzfeldt and Stoffel, 2006; Lu et al., 2005; Poy et al., 2004).
According to the miR2Disease database (Jiang et al., 2009)
that manually curates disease-associated miRNAs, both down-
and upregulated miRNA dysregulation are equally prevalent.
Downregulation of miRNAs in diseased tissue can lead to
aberrant expression of their target genes. Such genes are
deemed ‘‘physiological targets’’ because their expression is
tightly regulated by miRNAs in normal tissues. Conversely, up-
regulation of miRNAs in diseased tissue can further downregu-
late their physiological targets, preventing normal cell function.
In addition, upregulated miRNAs are able to downregulate
‘‘apparent nonphysiological targets,’’ which correspond to
genes bearing miRNA binding sites that in the wild-type situa-
tion are unaffected. Therefore, identifying both physiological
and apparent nonphysiological targets of miRNAs is essential
for understanding the complex gene regulation by miRNAs in
diseased tissues.
Target gene identification of miRNAs is challenging because
they bind to their target mRNAs by partial complementarity
over a short sequence and the rules of miRNA-mRNA interac-
tions are not fully understood. Unlike the related siRNAs that
require a perfect complementary match for cleavage of target
mRNAs, miRNAs allow mismatches at positions 1, 9, or 10 rela-
tive to their 50 end, whereas Watson-Crick pairing at positions
2–8, referred to as the ‘‘seed’’ region, is the minimal sequence
required for silencing of their targets (Brennecke et al., 2005).
In addition, despite the large number of target genes predicted
to be affected by miRNA loss of function, individual miRNA
knockouts lack strong phenotypic consequences. For example,
in C. elegans, the majority of individual miRNA mutants display
no major phenotype (Miska et al., 2007).
Use of miRNA target prediction algorithms has been valuable
in identifying targets of many different miRNAs. However, these
prediction algorithms are still not complete. Target prediction
algorithms typically predict hundreds to thousands of target
genes for an individual miRNA (Betel et al., 2010; Paraskevo-
poulou et al., 2013; Reczko et al., 2012; Ruby et al., 2007). How-
ever, most of these predicted genes may not correspond to
true targets (Alexiou et al., 2009), and the algorithms often fail
to identify validated miRNA targets (Johnson et al., 2005; Lal
et al., 2009). Another complication is that predictions from
several different algorithms generate lists of target genes with
very little overlap, making decisions about which predictions
to investigate difficult. Last, the majority of these predictions
lack experimental validations.
Here, we devised a general ‘‘reverse approach’’ strategy for
rapidly identifying targets of miRNAswhereby, rather than study-
ing specific miRNAs, we screened the 30 UTR of individual
genes against miRNAs. Specifically, we screened the effect of
132 distinct miRNAs on the 30 UTR of nine core components of
the Hedgehog (Hh) signaling pathway, leading us to identify 59
miRNA-target interactions. The Hh pathway controls multiple
developmental processes such as differentiation, pattern forma-
tion, and proliferation in various animals ranging from Drosophila
to humans (Ingham et al., 2011; Jiang and Hui, 2008; McMahon
et al., 2003). In addition, aberrant activation of Hh signaling in
humans has been linked to growth and maintenance of various
cancers (Barakat et al., 2010; Fan et al., 2004; Jiang and Hui,
2008; Kayed et al., 2004; Ruiz i Altaba, 1999; Taipale and
Beachy, 2001; Watkins et al., 2003). We discuss how our exper-
imentally based miRNA-target interactions approach compare
to those obtained with the three most popularly used target pre-
diction algorithms. Further, we focus on one miRNA, miR-14,
that we find to regulate the 30 UTRs of three Hh pathway compo-
nents. In vivo analysis of miR-14 targets shows how depending
on its level of expression, a single miRNA targets different com-
ponents of the same pathway and highlight the importance of
identifying miRNA targets at different miRNA expression levels
to fully understand loss or gain of function miRNA phenotypes.
RESULTS
Construction of miRNA Screening Platform for
Screening Hh Pathway Components in Tissue Culture
Cells
To facilitate the rapid identification of miRNAs that regulate core
components of the Hh pathway, we used a firefly luciferase
reporter to assay miRNA activity in Drosophila S2R+ cells. We
constructed luciferase reporters for nine core components of
the Hh pathway by cloning their 30 UTR downstream of the firefly
luciferase (Table S1). In addition, for the miRNA overexpression
library, we used our previously generated collection of 95 con-
structs (Bejarano et al., 2012) that we complemented with an
additional set of 33 constructs to increase the coverage of the
collection (see Experimental Procedures). Because some plas-
mids cover multiple miRNAs, our miRNA overexpression library
is composed of 128 overexpression plasmids covering 132
distinct miRNAs (see details in Table S2).
Next, to assess the activities of individual miRNAs, we
cotransfected the luciferase 30 UTR reporters with the miRNA
overexpression plasmids into S2R+ cells. After 72 hr, the firefly
luciferase levels were measured and normalized to the Renilla
luciferase levels (Figure 1A). For each miRNA-target gene pair,
we computed a negative log2 median fold change (LMF) score,
where the higher LMF score corresponds to stronger repression
of the target gene by the miRNA (Table S2).
Using the TargetScan (Ruby et al., 2007), DIANA (Paraskevo-
poulou et al., 2013; Reczko et al., 2012) and miRanda (Betel
et al., 2010) target prediction databases, we compiled a list
ofmiRNAs predicted to regulate the 30 UTRs of Hh pathway com-
ponents (Table S3). For each predicted miRNA-target pair, we
extracted the confidence score assigned by individual tools.
We only considered the miRNAs that are part of our screeningClibrary and used the least stringent cutoff values for each tool
to compile all possible miRNA-target predictions. Systematic
comparison of the LMF score to the predicted confidence score
reveals a weak but significant positive correlation (Figures
1B–1D). Furthermore, the median LMF scores increase as the
number of prediction tools supporting the miRNA-target pair in-
creases (Figure 1E). This suggests that the pairs with high LMF
score are likely to be predicted bymultiple target prediction tools
as high-confidence miRNA-target pairs and demonstrate the
reliability of the LMF scores.
Next, to systematically evaluate the performance of LMF
scores, we created a positive reference set (PRS) and a random
reference set (RRS). The PRS includes 24 miRNA-target pairs
validated from the literature (six pairs) and complemented with
high-confidence predictions (18 pairs). We constructed 1,000
RRS sets sampled from 736 nonspecific miRNA-target pairs
(Table S4) (see Experimental Procedures). Analysis of true-posi-
tive rates (TPRs) and false-positive rates (FPRs) at various cutoff
reveals robust performanceof theLMFscore (area under receiver
operating characteristic [ROC] curve = 0.8). Furthermore, this
analysis also facilitated the identification of appropriate cutoff
value (LMF scoreR0.622) at which we achieved 33% TPR and
3% FPR (Figure 1F). Using this cutoff value, we generated a
miRNA-target interaction network composed of 59 interactions
connecting 43miRNAs to nine Hhpathwaymembers (Figure 1G).
Strikingly, all nine Hh pathway 30 UTR reporters responded to
multiplemiRNAs. Consistent with this result, computational anal-
ysis ofmiRNA target sites indicated thatmost genes bear binding
sites of multiple miRNAs (Enright et al., 2003; Gru¨n et al., 2005;
Lewis et al., 2003; Maragkakis et al., 2011). Out of our 59
miRNA-target interactions, nine were supported by at least one
of the three target-prediction algorithms, 16 were supported by
two of the three target-prediction algorithms, and 11 were sup-
ported by all three (Figure 1H). In addition, we identified 23
miRNA-target interactions that were not predicted by any of the
three target-prediction algorithms highlighting the limitation of
the existing algorithms and the need for functional tests.
We identified 43 miRNAs that reduced the activity of the
reporters and therefore constitute potential regulators of the
Hh pathway. Of these, 30miRNAs regulated a single Hh pathway
component, whereas 13 miRNAs regulated multiple compo-
nents. We selected miR-14, which was found to regulate both
activators (hh and smoothened [smo]) and an inhibitor (patched
[ptc]) of the Hh pathway (Figure 1G), for further characterization.
In Vitro Validations ofmiR-14 Targets
We asked whether miR-14 indeed targets hh, ptc, and smo by
directly binding to its miRNA responsive elements (MREs) within
their 30 UTRs. To identify possiblemiR-14MREs in the 30 UTR of
each target gene, we used RNAhybrid (Rehmsmeier et al., 2004),
a bioinformatics tool for finding the minimum free energy
(mfe) hybridization sites for miRNAs. For each target gene, we
selected the top candidate MREs based on their mfe scores
and seed pairing rules and mutated the sequence complemen-
tary to the miR-14 seed (Figure 2A). Mutating the potential
MREs within the 30 UTRs partially (hh and smo) and completely
(ptc) relieved the suppression elicited by the addition of miR-
14 (Figure 2B). The partial rescue of the luciferase signalsell Reports 7, 2066–2077, June 26, 2014 ª2014 The Authors 2067
(legend on next page)
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Figure 2. In Vitro Validations of miR-14 Target Genes
(A) Potential miR-14 binding sites within the 30 UTRs of the three candidate target genes. All predicted binding sites were mutated as shown in red.
(B) Secondary luciferase reporter assay.miR-14was screened against wild-type and mutated 30 UTRs to determine if the repressive activity ofmiR-14 requires a
direct interaction between miR-14 and the predicted binding sites within the 30 UTRs of the candidate target genes. Mutating the miR-14 binding sites relieved
repression. **p < 0.001 and *p < 0.05.observed with the mutated MREs and miR-14 is most likely due
to additional, potentially still functional, miR-14 MREs that were
not mutated (Figures S1A–S1C). Collectively, these results
demonstrate that direct interactions between miR-14 and the
MREs located within the 30 UTR of the target genes are respon-
sible for suppression of the luciferase signal.Figure 1. Screen for miRNAs that Regulates Hh Signaling Pathway Co
(A) Outline of the primary screen. Genome-wide collection of 128 Drosophila miR
against the luciferase 30 UTR reporters of nine core genes of the Hh pathway.
(B–D) Systematic comparison of the LMF scores from the entire screen to the pred
Gray dashed lines mark the LMF score cutoff value (LMF scoreR0.622). Blue lin
score from target prediction algorithms. Note that the confidence scores for miR
trend line. The significance of correlation is estimated using Pearson’s product m
(E) Comparison of the LMF scores to the miRNA-target pair predicted by number o
predicted by single tool (1) two tools (2) and three tools (3) compared to the pairs
significance of difference between two distributions. **p < 0.001 and *p < 0.05.
(F) Analysis of true-positive rates (TPR) and false-positive rates (FPR) at various LM
we achieved 33% TPR and 3% FPR. AUC, area under ROC curve.
(G) miRNA-target interaction network. The thickness of interaction lines indicat
increase.
(H) Venn diagram displaying the overlap of miRNA-target interaction predicted b
COverexpression ofmiR-14 Can Downregulate
Endogenous Levels of Hh Signaling Pathway Genes
To determine whether miR-14 affects Hh signaling in vivo, we
focused on the Drosophila wing, where Hh regulates both tissue
patterning and growth. Cells in the posterior (P) compartment
of the developing wing disc express the secreted ligand Hhmponents
NA overexpression plasmids that covers 132 distinct miRNAs were screened
icted confidence scores from TargetScan, miRanda, and DIANA, respectively.
es show the general correlation of the LMF score to the predicted confidence
anda (mirSVR score) increase as mirSVR scores decrease, thus the inverse in
oment correlation coefficient (R).
f tools. Box plots shows that the LMF score distributions of miRNA-target pairs
that are not predicted by any of the tools (0). Wilcoxon test was used to test the
F scores cutoffs. Gray boxmarks the cutoff value (LMF scoreR0.622) at which
es the range in LMF scores. The thickness in line increases as LMF scores
y individual prediction algorithms to the screen results.
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Figure 3. miR-14 Can Modulate Wing Size
by Regulating Hh Signaling
Area shaded in green (A–D) marks the region
where hh-Gal4 is active.
(A) Expression of hh-Gal4 in the wild-type back-
ground.
(B) Overexpression of miR-14 in the posterior
compartment causes curvature of the wing.
(C) RNAi against hh in the posterior compartment
phenocopies overexpression of miR-14 suggest-
ing that miR-14 modulates Hh activity.
(D) Removal of endogenous miR-14 restores the
curved wing phenotypes observed in (C).
(E) Quantification of P compartment wing size and
ratio of P compartment to the A compartment.
Reduction of hh expression by RNAi and over-
expression of miR-14 significantly reduces the
wing size of the P compartment. n = number of
wings quantified. **p < 0.001 and *p < 0.05.and induce ptc expression in the anterior (A) compartment to
establish the A-P boundary. Expression of Hh andSmo is highest
in the P compartment, whereas Ptc is exclusively expressed in
the A compartment at the A-P boundary. Because the hh, smo,
and ptc 30 UTRs are sensitive tomiR-14 expression, we hypoth-
esized that overexpressing miR-14 in the compartments where
these target genes are endogenously expressed should pheno-
copy their loss of function.
Reduction of Hh expression in the P compartment by RNAi
significantly decreased wing size, evident by the slight curving
of the wing toward the P compartment and by the quantification
of wing size (Figures 3C and 3E). This phenotype is likely due
to decreased Decapentaplegic (Dpp) signaling, a downstream
target of the Hh signaling that regulates proliferation in both A
and P compartments. Consequently, we also observed reduc-
tion in the A compartment, resulting in similar P/A compartment
ratio to wild-type control (Figure 3E). Interestingly, overexpres-
sion of miR-14 in the P compartment caused a significantly
greater P compartment wing size defect (Figures 3B and 3E).
One possibility is that, in addition to Hh, overexpression of
miR-14 in the P compartment represses factors that are required
for Hh signaling. Alternatively, factors that are required for
responding to Dpp signaling may also be target of miR-14. The
wing size defect observed with loss of Hh expression by RNAi2070 Cell Reports 7, 2066–2077, June 26, 2014 ª2014 The Authorswas restored when endogenous miR-14
was removed (Figure 3D), demonstrating
that endogenous miR-14 likely targets
Hh and not Ptc and Smo because Ptc is
not expressed in the P compartment,
and, whereas Smo levels are highest in
the P compartment, RNAi against smo
in the P compartment does not alter the
shape of the wing because Smo activity
is mainly required at the A-P boundary
and A compartment (Figure S2H) (Blair
and Ralston, 1997). Interestingly, removal
of endogenousmiR-14 in the presence of
hh-RNAi significantly increased the over-all size of the P compartment, further suggesting that additional
targets ofmiR-14 required for Hh and/or Dpp signaling may exist
(Figure 3E). However, overall increase in the size of the P
compartment was significantly less when compared to miR-14
loss-of-function allele (Figure 3E), suggesting that regulation of
Hh signaling bymiR-14 is partly to blame for the increase in over-
all wing size.
Ptc expression is highest at the A-P boundary and RNAi
against ptc elevates Hh activity in that region resulting in an
increased distance between the L3 and L4 wing veins (Figures
S2D and S20). Strikingly, overexpression of miR-14 exhibited
the opposite phenotype, decreasing the distance between the
L3 and L4 veins, resembling instead decreased Hh signaling
(Figures S2E–S2F0). One possible explanation is that because
several rows of cells near the P compartment at the A-P bound-
ary also express Smo, overexpression of miR-14 in this region
may inhibit both ptc and smo. Given that Ptc acts upstream of
Smo, overexpression ofmiR-14 will result in an overall decrease
in Hh signaling activity. Consistent with this, overexpression of
miR-14, as observedwith ptc-RNAi, in the A-P region partially re-
duces the distance between the L3 and L4 veins (Figures S2G
and S2G0), and RNAi against smo in the A-P boundary results
in a clear decrease in the L3 and L4 intervein region (Figure S2I).
In addition, overexpressing miR-14 in the A compartment also
Figure 4. Overexpression of miR-14
Reduces the Expression of Endogenous
Hh Signaling Pathway Genes
(A–D0 0 0) Hh, Ptc, Smo, and Dpp-lacZ stainings in
Drosophila third instar larva wing discs.Wing discs
are oriented dorsal (D) up, ventral (V) down, ante-
rior (A) left, and posterior (P) right. (A–D) Wild-type
discs stained for Hh, Ptc, Smo, and Dpp-lacZ. (A0–
D0) Expression of miR-14 induced in the dorsal
region of the wing disc using the ap-Gal4 driver
represses the expression of endogenous Hh, Ptc,
and Smo and the Hh target gene, Dpp. (A0 0–D0 0)
GFP expression marks the region where ap-Gal4
is active and miR-14 expression is induced. (A0 0 0–
D0 0 0) Magnified view of the boxed area in (A0 )–(D0).
Red dotted lines mark the ap-Gal4 boundary.reduced the overall size of the A compartment causing the wing
to curve in the anterior direction (Figure S2J). A likely model is
that miR-14 downregulates Smo levels in the A compartment,
thus preventing activation of the Hh pathway and resulting in a
smaller A compartment. In addition, overexpression of miR-14
in the entire wing decreases the size of the wing (Figure S2C).
These results collectively suggest that overexpression of miR-
14 in the wing leads to an overall reduction of Hh signaling.
To further evaluate the effect ofmiR-14, we examined directly
the protein levels of endogenous Hh, Ptc, and SmowhenmiR-14
was overexpressed. In wild-type wing discs, levels of Hh, Ptc,
and Smo are identical in the dorsal (D) and ventral (V) compart-
ments (Figures 4A–4C). However, whenmiR-14 is overexpressed
in the D compartment using ap-Gal4, the levels of Hh and Smo
were significantly reduced (Figures 4A–4A0 0 0 and 4C–4C0 0 0), indi-
cating that miR-14 can suppress the expression of endogenous
Hh and Smo. Interestingly, we observed little or no changes in
the levels of Ptc (Figures 4B–4B0 0 0). One possible explanation is
that because ptc is also a downstream target of Hh signaling,
reducing the levels of Ptc by overexpressing miR-14 will result
in increased expression of ptc, which nullifies the repression by
miR-14. Another possibility is that miR-14 may weakly regulate
Ptc in contrast toHh andSmo. In fact, we observed similar results
when all three 30 UTR sensors were treated withmiR-14. The ptc
sensor was less sensitive tomiR-14 treatment compared to both
the hh and smo sensors (Figure 2B). We favor the later explana-
tion because the repression of Smo was also weaker whenCell Reports 7, 2066–207compared to Hh (Figures 4A–4A0 0 0 and
4C–4C0 0 0) and similar results were also
observed with their respective sensors
(Figure 2B). Collectively, our results sug-
gest that overexpression of miR-14 can
suppress the expression of endogenous
Hh, Ptc, and Smo at varying levels.
Because overexpression of miR-14
can inhibit both positive (Hh and Smo)
and negative (Ptc) regulators of the Hh
pathway at varying levels, we analyzed
the effect of miR-14 overexpression on
Hh pathway signaling output using Dpp
expression as readout. Strikingly, Dppexpression was significantly reduced (Figures 4D–4D0 0 0), demon-
strating that overexpression of miR-14, which can inhibit the
endogenous expression of both positive and negative regulators
of the Hh pathway, overall exerts a negative effect on Hh
signaling activity when expressed at high levels.
Endogenous miR-14 Regulates Hh Levels
Because overexpression ofmiR-14 downregulates protein levels
of endogenous Hh, Ptc, and Smo, we tested whether endoge-
nous miR-14 also represses these genes in vivo and therefore
represent physiological targets. A previous study using a miR-
14 sensor has shown that miR-14 is ubiquitously expressed
throughout the entire wing disc and miR-14 homozygous mu-
tants are viable (Varghese et al., 2010). To determine whether
miR-14 mutants display any wing phenotypes suggestive of Hh
signaling deregulation, we compared the adult wing area of
miR-14 mutant flies and found that miR-14 mutant wings are
18% larger than wild-type (Figures 5A and 5B). To test whether
the increased wing size is due to elevated Hh activity, we
reduced Hh level by RNAi in the miR-14 mutant background.
Reducing the amount of Hh activity in the mutants partially, but
significantly, restored wing size (Figure 5B), suggesting that
increased Hh signaling in miR-14 mutants is at least in part
responsible for the increased wing size.
Next, using a gain-of-function allele of hh called Moonrat
(hhMrt), which primarily affects the anterior region of the wing
(Felsenfeld and Kennison, 1995), we asked whether loss of7, June 26, 2014 ª2014 The Authors 2071
Figure 5. Endogenous miR-14 Modulates Hh Expression
(A) Wild-type wing (blue) superimposed with miR-14 mutant wing (magenta).
(B) Quantification of wing size from wild-type and miR-14 mutants. Wing size defect is partially, but significantly restored when hh levels are reduced by RNAi.
**p < 0.001.
(C) Severity of hhMrtwing phenotypes displayed in three classes, from mild to strong. Arrowhead marks the region where sensory bristles are missing. L2 and L3
mark the two major veins of the wing.
(D) Distribution of hhMrt wing phenotypes. ‘‘n’’ denotes the number of wings counted for each genotype; in parenthesis is the percentage of wings showing the
phenotype. Absence of miR-14 enhances both class II and III hhMrt phenotypes (c2 = 9.27, *p < 0.01). Significance calculated using a chi-square test for
comparing frequencies.miR-14 could enhance the Mrt wing defects. For quantification
purposes, we assigned mutant wing phenotypes to three
different classes based on their severity. In class I Mrt pheno-
type, distal anterior region of the wing is slightly expanded with
wing vein L2 partially duplicated. In class II, the distal anterior re-
gion of the wing is expanded and rounded. The L2 wing vein is
frequently duplicated proximally and absent distally, whereas
L3 vein is thickened distally. In class III, anterior compartment
is almost completely rounded and all phenotypes observed in
class II are present, but are more severe; often, both L2 and L3
veins are elaborately broadened. These are also associated
with frequent loss of sensory bristles in the anterior region of
the wing (Figure 5C). Removing both copies of miR-14 partially,
but significantly, enhanced the frequency of class II and III Mrt
phenotypes (Figure 5D), suggesting that endogenous miR-14
prevents further enhancement of the Hh activity of hhMrt.
miR-14Ensures theCorrect Number of Terminal Cells in
the Tracheal System by Regulating Hh Activity
To determine whether miR-14 can regulate Hh signaling in tis-
sues other than the wing, we examined the Drosophila larval
tracheal system where Hh signaling plays an important role
in determining terminal cell fates (Glazer and Shilo, 2001). In
the dorsal tracheal branch, which typically consists of five or
six cells, one cell at the branch tip adopts the terminal cell
fate marked by the expression of the serum response factor
(SRF) (Guillemin et al., 1996). In addition, a second cell at the
branch tip adopts a fusion cell fate and mediates fusion2072 Cell Reports 7, 2066–2077, June 26, 2014 ª2014 The Authorsof tracheal branches from the contralateral branches at
the dorsal midline (Samakovlis et al., 1996a, 1996b). The
two terminal cells from each side then branch extensively to
deliver oxygen to neighboring tissues (Samakovlis et al.,
1996a, 1996b) (Figure 6A).
Animals with excess levels of Hh signaling exhibit extra SRF-
expressing cells that appear to arise from the branch cells
located after the fusion cell (Glazer and Shilo, 2001). Because
miR-14 regulates the expression levels of Hh in the wing,
we tested whether miR-14 mutant larvae have defects in the
number of terminal cells in the dorsal tracheal branches. Strik-
ingly, miR-14 mutant larvae possess extra SRF expressing
cells (Figures 6B–6B0 0), and expression of UAS-miR-14, using
the trachea-specific Gal4 driver, btl-Gal4, in miR-14 mutant
larvae, rescued the excess terminal cell phenotype (Figure 6C).
Next, we tested whether the excess in terminal cells in miR-14
mutant larvae results from an increase in Hh signaling activity.
To reduce Hh activity, we either introduced the hh loss of func-
tion allele, hhAC, or induced RNAi against hh in the miR-14
mutant background and quantified the number of terminal
cells. Strikingly, in both hhAC heterozygotes and hh-RNAi ani-
mals, a reduction of excess terminal cells was observed in
miR-14 mutant larvae (Figure 6C), indicating that regulation of
Hh signaling by miR-14 is critical for determining the correct
number of terminal cells. Collectively, our results from both
the wing and the tracheal system indicate that miR-14 regu-
lates Hh signaling, a mechanism that may also extend to other
tissues.
Figure 6. miR-14 Regulates Hh Signaling in the Larval Tracheal System
(A) Dorsal branches of wild-type third instar larva trachea under bright field illumination.
(B) Dorsal branches of miR-14 mutants. In wild-type, the two dorsal branches fuse and give rise to two terminal cells with multiple terminal branches, whereas
miR-14 mutants show excess terminal cells.
(A0 and B0) Terminal cells are marked using the terminal cell-specific Gal4 driver, SRF-Gal4, driving expression of EGFP.
(A0 0 and B0 0) Merged images of dorsal branches and labeled terminal cells.
(C) Quantitative analysis of terminal cell numbers in labeled genotypes. miR-14 mutants exhibit more frequent instances of excess terminal cells, as observed
whenHh is overexpressed (btl-Gal4>UAS-hh). Removing one functional allele of hh (miR-14D: hhAC/+) or RNAi against hh (miR-14D: hh-Gal4 / UAS-hh-RNAi) in the
miR-14 mutant background restores the proper number of terminal cells. n, the number of dorsal branch pair examined. *p < 0.05.hh Is a Physiological Target of Endogenous miR-14
To further investigate the regulation of target genes by endoge-
nousmiR-14, wemeasured the endogenous protein levels of Hh,
Ptc, and Smo from whole pupae extracts. Hh levels were signif-
icantly elevated inmiR-14mutants, whereas Ptc and Smo levels
remained relatively unchanged (Figures 7A and 7B), suggesting
that endogenous miR-14 primarily functions to dampen Hh
signaling by modulating Hh expression, but not Ptc or Smo.
Because miRNAs can also destabilize their target mRNAs, we
checked the transcript levels of hh, ptc, and smo from total RNA
of whole pupae. As expected, hh transcripts were elevated in
miR-14mutants (Figure 7C). Interestingly, ptcmRNAs increased
by nearly 3-fold in the mutants whereas smo levels were
increased by 2-fold (Figure 7C). Because ptc is also a direct
target of the Hh pathway, one possibility is that increased Hh
signaling activity in miR-14 mutants caused an increase in ptc
transcript levels. Although it is unclear why an increase in ptc
and smo transcript levels do not translate intomore protein levels
inmiR-14mutants, an alternative mechanism regulating Ptc and
Smo proteins production in miR-14 mutants may exist. Alterna-
tively, increase in both ptc and smo transcript levels might be
an indirect effect of removing endogenousmiR-14. It is possible,
given the ability of miRNAs to regulate many different processes,
that miR-14 indirectly regulates the expression of ptc and smo.
We also measured the expression levels of Hh target genes,
wg and dpp, and found that both genes were increased in the
miR-14 mutants (Figure 7C). To investigate whether increase in
wg and dpp levels leads to hyperactivation of the Wg and Dpp
signaling pathways, we examined the expression levels of the
Wg target gene, senseless, and Dpp target genes, spalt andComb. As expected, the levels of all three target genes were
elevated in themiR-14mutant (Figure 7C). Although it is possible
that all three genes are also physiological targets ofmiR-14, it is
most likely an indirect result of increased Hh signaling in themiR-
14mutant because bothWg and Dpp pathways are downstream
of Hh signaling. These results collectively show that endogenous
miR-14 maintains the proper balance of Hh signaling activity by
primarily regulating Hh expression, a physiological target, but
not Ptc and Smo, supporting the model that they likely represent
apparent nonphysiological targets (Figure 7D).
DISCUSSION
Previous miRNA gain-of-function studies using specific pheno-
types and pathway sensors as readouts generated many inter-
esting phenotypes and identified several candidate miRNAs in
specific signaling pathways (Bejarano et al., 2012; Silver et al.,
2007; Szuplewski et al., 2012). However, these approaches
faced difficulties in identifying biologically significant targets.
Here, we designed a fast and efficient approach to identify
miRNA targets, whereby rather than studying the function of in-
dividual miRNAs, we screen for all possible targets of all miRNAs
in a given signaling pathway. This study uses a genome-wide
collection of Drosophila miRNAs to screen for potential target
genes among specific components of a signaling pathway.
Using luciferase as readout, we were able to quickly and easily
measure the effect that different miRNAs have on the genes
being interrogated. This systematic miRNA screening platform
can be used to elucidate miRNA-target relationships for genes
in various other processes.ell Reports 7, 2066–2077, June 26, 2014 ª2014 The Authors 2073
Figure 7. Hh Is a Physiological Target of miR-14
(A) Western blot analysis of miR-14 mutant pupae. Absence of miR-14 results in elevated Hh protein levels, whereas Ptc and Smo levels remain relatively
unaffected. a-Tubulin was used as loading control.
(B) Quantitative analysis of the western blot from (A).
(C) Quantitative PCR analysis frommiR-14mutant pupae. Levels of three Hh pathway genes hh, ptc, and smo are upregulated inmiR-14mutants. Target genes of
Hh signaling wg and dpp, and their respective target genes are also upregulated in miR-14 mutant pupae. Levels of EcR, a validated target of miR-14, and its
downstream target genes, E74, E93, and Fbp1, are elevated. **p < 0.001 and *p < 0.05.
(D) Model showing regulation of hh signaling pathway by miR-14. Genes labeled in green or red represent predominantly positive or negative regulators of the
pathway, respectively. (Left) During normal development, miR-14 regulates Hh signaling by buffering Hh levels. Physiological regulation of both Ptc and Smo
might also exist, yet no such evidence has been identified in our current work. (Middle) Overexpression ofmiR-14 results in strong repression of Hh as well as its
apparent nonphysiological targets, Ptc and Smo, resulting in decreased Hh signaling. (Right) In the absence ofmiR-14, Hh levels increase resulting in increased
Hh signaling.
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Systematic performance evaluation of the LMF scores by
analyzing the TPR and FPR allowed us to identify an appropriate
cutoff value at which we achieved 33% TPR and 3% FPR. Our
cutoff was stringent enough that previously identified interac-
tions between miR-12 and Costal-2 (Cos2) and miR-283 and
Fu were included, but interactions with smo were excluded
(Friggi-Grelin et al., 2008). Evaluation of our screen results to
three of the popularly used prediction algorithms demonstrated
that there is a positive correlation between the LMF scores and
the number of miRNA-target predictions made. Furthermore,
our screen revealed 23 miRNA-target interactions, representing
39% of the total miRNA-target interactions. Interestingly, the
miR-14-hh interaction was predicted by only one prediction
algorithm, whereas miR-14-ptc and miR-14-smo interactions
were identified by multiple algorithms. Furthermore, miR-14-hh
interaction was only predicted when the least stringent cutoff
value was used. The miRNA target gene (miTG) score assigned
by DIANA for miR-14-hh is 0.212, which is much lower than the
high-confidence miTG score of R0.5. This result further high-
lights the limitation of the existing algorithms and the need for
functional tests.
We identified and characterized in detailmiR-14 that can regu-
late three components of the Hh pathway, hh, ptc, and smo. We
have shown thatmiR-14 overexpression can decrease the levels
of all three proteins at varying levels and cause an overall
decrease in Hh signaling as evidenced by the reduction of Dpp
expression in the wing imaginal discs and by the adult wing
outgrowth. We have also presented evidence that this regula-
tion is mediated through the direct binding of miR-14 seed
sequences to the miR-14 MREs located within the 30 UTRs of
all three genes. We have also presented data demonstrating
that hh is a physiological target of miR-14, whereas ptc and
smo appear to be nonphysiological targets. However, there are
several alternative explanations that might impede us from cate-
gorizing both ptc and smo as physiological targets. For example,
regulation of Ptc and Smo bymiR-14may be very weak and not
detectable by western blot analysis. In fact, the effect of an indi-
vidual miRNA on a protein target level tends to be subtle, usually
less than 2-fold (Baek et al., 2008). In support of this explanation,
the amount of repression elicited bymiR-14 on both ptc and smo
30 UTR sensors and Ptc and Smo levels in the wing discs are far
less robust compared to Hh. Alternatively, additional miRNAs
may act in a combinatorial manner and downregulate Ptc and
Smo even in the absence ofmiR-14. In fact, our screen identified
several other miRNAs that can also reduce the ptc and smo
sensor levels. Finally, because Hh negatively regulates Ptc
levels, derepression of Ptc in miR-14 mutants maybe nullified
by the increased levels of Hh.
Although miR-14 is well conserved in distantly related
Drosophila species, it is missing in vertebrates such as Zebra-
fish and humans. Nevertheless, regulation of Hh signaling by
miRNAs seems to be conserved across diverse species. For
example, Suppressor of fused (Su(fu)) is targeted by miR-214
in Zebrafish to enable precise specification of muscle cell types
by sharpening cellular responses to Hh (Flynt et al., 2007). In non-
small-cell lung cancer cell line, miR-212 acts as oncogene by
targeting PTCH1, human homolog of Drosophila Ptc, to increase
cell proliferation, migration, and invasion (Li et al., 2012),Cwhereas in chronic myeloid leukemia (CML), miR-326 targets
Smo to decrease cell proliferation and increase apoptosis
(Babashah et al., 2013).
Although, ptc and smo seem to be apparent nonphysiological
targets ofmiR-14, this information is valuable because dysregula-
tion of miRNAs are common features of many diseases. In addi-
tion, given that miRNA replacement therapies are currently being
tested as possible treatments for various diseases, information
regarding apparent nonphysiological targets becomes very
important to prevent unnecessary side effects. Therefore, consid-
ering the importance of identifying both physiological and
apparent nonphysiological targets, we propose that our fast and
efficient approach of identifying miRNA targets can help under-
stand the complex gene regulatory network of miRNAs.
EXPERIMENTAL PROCEDURES
DNA Constructs and Cloning
Reporter plasmids were constructed by cloning firefly luciferase into the KpnI/
EcoRI site of pAc5.1/V5-His C (Invitrogen). Next, the 30 UTR of each target
gene was cloned into the EcoRI/SacI site, with the exception of Fu that was
cloned into the NheI/SacI site. The 30 UTR for individual genes was cloned
based on annotated sequences provided by Flybase (http://www.flybase.
org). A complete list of 30 UTR primers can be found in Table S1.
Most miRNA overexpression plasmids used to prepare the screening plat-
form have been previously described (UAS-dsRed-miRNA collection
described in Bejarano et al., 2012). To expand coverage, we prepared 33 addi-
tional miRNAs overexpression plasmids by amplifying400–700 nt fragments
encompassing miRNA genes from genomic DNA and cloned them into
pAc5.1/V5-His C. Altogether, the resource comprises 128 miRNA overexpres-
sion plasmids that covers 132 distinct miRNAs (Table S2). Note that we chose
to clone the newmiRNAs into a vector under the control of constitutively active
Actin promoter rather than UAS to minimize the number of plasmids needed
for transfection. Prior to constructing the additional miRNA constructs, we
compared the knockdown efficiency of senseless 30 UTR reporter, which
has been previously shown to be regulated by miR-9a (Li et al., 2006), using
both pAc and UAS vectors. Both pAc-miR-9a and UAS-dsRed-miR-9a over-
expression plasmids were equally effective at reducing the luciferase level of
senseless 30 UTR reporter (Figure S3).
A complete list of miRNAs can be found in Table S2. Primer sequences will
be provided upon request. The screening platform will be publicly available at
the Drosophila RNAi Screening Center (DRSC).
To mutate the seed sequence ofmiR-14 and potential MREs in the 30 UTRs
of target genes, we followed the instructions of QuikChange II XL Site-Directed
Mutagenesis Kit (Stratagene).
Luciferase Reporter Assay
Drosophila S2R+ cells were maintained in Schneider’s Drosophila Medium
(Gibco) with 10% heat-inactivated FBS (Sigma) and 1% Pen/Strep (Gibco) at
25C. Experiments were performed in 96-well plates excluding the outer wells.
The wells were seeded with 20 ng of plasmid expressing pAc-miRNAs or 20 ng
of plasmid expressing UAS-dsRed-miRNAs and 5 ng of Actin-Gal4 plasmid
prior to the start of the experiment. Each well was transfected with 5 ng of
firefly luciferase reporter plasmid and 5 ng of Renilla luciferase reporter
plasmid for transfection control. Transfection was performed using Effectene
Transfection Reagent (QIAGEN). After 72 hr, luciferase activities were
measured using DualGlo (Promega).
Computing miRNA-Target Interaction Score
We computed the normalized fold change value x for the given miRNA i and 30
UTR region of gene j as follows:
xij =
ðSij
ðUj

CÞÞ
ðMi=CÞ ;ell Reports 7, 2066–2077, June 26, 2014 ª2014 The Authors 2075
where Sij is normalized firefly signal (ratio of firefly/Renilla luciferase levels)
from the tested pair of miRNA i and 30 UTR of gene j, Uj is signal from 30
UTR control (lacking miRNA) and Mi is signal from miRNA control (lacking 3
0
UTR). C is the signal from control without both 30 UTR and miRNA. Next, we
computed the median of fold change values (~x) from the three replicates.
The negative log2 median LMF is computed as:
LMFij =  log2ð~xijÞ:
Integrative Analysis with a Predicted miRNA-Target Network
To compare the LMF score with predicted miRNA target, we collected the
potential miRNAs that could regulate the Hh pathway members from
TargetScan (http://www.targetscan.org/) (Ruby et al., 2007), miRanda
(http://www.microrna.org/microrna/home.do) (Betel et al., 2010), and DIANA
(http://diana.cslab.ece.ntua.gr/) (Paraskevopoulou et al., 2013; Reczko et al.,
2012) databases. For all three databases, least cutoff values were used to
extract all possible miRNA-target relations and each extracted pair was asso-
ciated with respective scores assigned by the tools (Branch-Length score for
TargetScan, miRNA Support Vector Regression (mirSVR) score for miRanda
andmiTG score for DIANA). The trend linewas fitted using the linear regression
model (LMF Prediction score) implemented in R (http://www.r-project.org/).
All the integrative analyses were performed using in-house developed perl
scripts.
Validation of LMF Score Performance
In order to choose the LMF cutoff value, we created a positive reference set
(PRS) and a random reference set (RRS). The PRS includes 24 miRNA-target
gene (member of Hh pathway) interactions curated from literature (six pairs)
and high-confidence predictions (18 pairs) that overlap with our screening
space. High-confidence miRNA-target interactions refer to the pairs that are
predicted by two or more independent tools as high-confidence interactions
(TargetScan: branch-length score R0.8; miRanda: mirSVR score % 0.5;
DIANA: miTG score R 0.5). To construct RRS, we first compiled a list of 736
potential noninteracting pairs from the screening space (1,160 possible pairs)
that are not overlapping with PRS and not predicted asmiRNA target by any of
the tools even with the least stringency cutoff. From this potential noninter-
acting pairs, we randomly sampled 1,000 RRS sets (size of each RRS is equal
to the size of PRS). We analyzed the true-positive rate (TPR) and false-positive
rate (FPR) values for various LMF score cutoff values. For a given LMF score
cutoff value i, the TPR and FPR are computed as follows:
TPRi =
TPi
ðTPi +FNiÞ
FPRi =
FPi
ðFPi +TNiÞ
i ˛ fLMFj  1:5% LMF % 2g:
TPi, FNi, FPi, and TNi correspond to true-positive, false-negative, false-posi-
tive, and true-negative values at given LMF cutoff value i, respectively. The
Hh miRNA-target network was constructed using at chosen cutoff value
(LMF R 0.62). The network is visualized with Cytoscape software (http://
www.cytoscape.org/).
Immunostaining, Confocal Imaging, and Analysis
Immunostainings of larval wing imaginal discs were performed as previously
described (Belenkaya et al., 2004). Primary antibodies were mouse anti-Ptc
(1:40; DSHB, Apa-1), mouse anti-Smo (1:50; DSHB, 20C6), rabbit anti-Hh
(1:50; kindly provided by Dr. Xinhua Lin), and rabbit anti-b-Gal (1:1000;
Cappel). Primary antibodies were detected by anti-mouse or anti-rabbit sec-
ondary antibodies conjugated to Alexa-Fluor 594 and 647 (1:1,000; Invitrogen).
Fluorescent images were acquired with a Leica TCS SP2 AOBS. Images
were processed using Adobe Photoshop.2076 Cell Reports 7, 2066–2077, June 26, 2014 ª2014 The AuthorsTracheal Terminal Branch Imaging and Analysis
Third instar larvae were heat killed (70C for 10–15 s), mounted in 50% glycerol
and examined under a Zeiss Axioskop 2 compound fluorescence microscope.
Average values and their corresponding SDs were calculated, and t test anal-
ysis was performed with Microsoft Excel.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and four tables and can be found with this article online at
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